HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Hersey Selected Research

P Hersey Research Topics

Disease

28Melanoma (Melanoma, Malignant)
01/2020 - 04/2000
3Necrosis
06/2013 - 07/2000
2Disease Progression
01/2019 - 08/2009
1Neoplasms (Cancer)
05/2014
1Rupture
06/2013
1Sarcoma (Soft Tissue Sarcoma)
06/2013
1Neoplasm Metastasis (Metastasis)
11/2005
1B-Cell Lymphoma (Lymphoma, B Cell)
11/2000

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
05/2014 - 08/2009
5TNF-Related Apoptosis-Inducing LigandIBA
08/2010 - 04/2000
3Small Interfering RNA (siRNA)IBA
06/2013 - 08/2010
3LigandsIBA
10/2001 - 10/2000
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2001 - 11/2000
3NF-kappa B (NF-kB)IBA
05/2001 - 07/2000
2AntibodiesIBA
01/2020 - 11/2005
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2016 - 05/2014
2PLX 4720IBA
05/2014 - 09/2010
2Messenger RNA (mRNA)IBA
05/2014 - 09/2010
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
05/2014 - 11/2005
2CaspasesIBA
06/2013 - 11/2000
2Caspase 3 (Caspase-3)IBA
06/2013 - 10/2001
2Caspase 8 (Caspase-8)IBA
08/2010 - 11/2000
2DNA (Deoxyribonucleic Acid)IBA
08/2009 - 11/2007
2Peptides (Polypeptides)IBA
08/2009 - 07/2008
2VaccinesIBA
08/2009 - 07/2008
2Temozolomide (Temodar)FDA LinkGeneric
04/2009 - 11/2007
2Interleukin-2 (IL2)IBA
07/2008 - 07/2000
2Monophenol Monooxygenase (Tyrosinase)IBA
07/2008 - 01/2001
2Death Domain ReceptorsIBA
10/2001 - 05/2001
2Proteasome InhibitorsIBA
05/2001 - 03/2001
1Programmed Cell Death 1 ReceptorIBA
01/2020
1pembrolizumabIBA
01/2019
1U 0126 (UO 126)IBA
05/2014
1Eukaryotic Initiation Factor-4EIBA
05/2014
1VemurafenibIBA
06/2013
1Annexin A5IBA
06/2013
1necrostatin-1IBA
06/2013
1Histone Deacetylases (Histone Deacetylase)IBA
06/2013
1Propidium (Propidium Iodide)IBA
06/2013
1Protein Kinases (Protein Kinase)IBA
06/2013
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
06/2012
1Proto-Oncogene Protein c-ets-1IBA
08/2011
1Protein Isoforms (Isoforms)IBA
09/2010
1CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA
08/2010
1Cystatin BIBA
08/2010
1Cathepsin BIBA
08/2010
1Cysteine Proteases (Cysteine Protease)IBA
08/2010
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
08/2010
1interleukin-21 (interleukin 21)IBA
08/2009
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
08/2009
1RNA (Ribonucleic Acid)IBA
08/2009
1Monoclonal AntibodiesIBA
08/2009
1Sunitinib (Sutent)FDA Link
08/2009
1Biomarkers (Surrogate Marker)IBA
08/2009
1Dasatinib (BMS 354825)FDA Link
08/2009
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
08/2009
1Imatinib Mesylate (Gleevec)FDA Link
08/2009
1Apoptosis Regulatory ProteinsIBA
08/2009
1CTLA-4 AntigenIBA
08/2009
1O(6)-Methylguanine-DNA MethyltransferaseIBA
04/2009
1lomeguatribIBA
04/2009
1Alkylating AgentsIBA
11/2007
1GuanineIBA
11/2007
1A-Form DNA (A-DNA)IBA
11/2007
1Formaldehyde (Formol)FDA Link
11/2005
1MART-1 AntigenIBA
11/2001
1AntigensIBA
11/2001
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
10/2001
1caspase-activated DNase inhibitorIBA
10/2001
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
10/2001
1Interleukin-10 (Interleukin 10)IBA
06/2001
1ApoferritinsIBA
06/2001
1NF-KappaB Inhibitor alphaIBA
05/2001
1Cytochromes c (Cytochrome c)IBA
11/2000
1Caspase 9IBA
11/2000
1Fas Ligand Protein (Fas Ligand)IBA
11/2000
1Matrix Metalloproteinases (MMPs)IBA
11/2000
1Effector CaspasesIBA
11/2000
1CytokinesIBA
07/2000
1Complementary DNA (cDNA)IBA
04/2000

Therapy/Procedure

4Therapeutics
01/2020 - 07/2000
3Immunotherapy
08/2009 - 07/2000
2Drug Therapy (Chemotherapy)
08/2009 - 11/2001
1Withholding Treatment
01/2020
1Immunomodulation
08/2009